Evidence map›Paper›PMID 32853206›Full record

ArticlePLoS neglected tropical diseases2020

Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment.

Vitor Hugo Simões Miranda, Talita Rocha Gomes, Dirli Emerick Eller, Lorena de Cássia Neres Ferraz, Ana Thereza Chaves, Kelly Alves Bicalho, Carlos Eduardo Calzavara Silva, Alexander Birbrair, Marcelo Antônio Pascoal Xavier, Alfredo Miranda de Goes and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Glioma Pericytes Promote Angiogenesis by Producing Periostin.Cellular and molecular neurobiology · 2022
    Review
  5. Circulating Nestin-GFPStem cell reviews and reports · 2021
    Article
  6. Sensory nerves in the spotlight of the stem cell niche.Stem cells translational medicine · 2021
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Vitor Hugo Simões MirandaInstituto René Rachou, Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.
Talita Rocha GomesInstituto René Rachou, Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.
Dirli Emerick EllerInstituto René Rachou, Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.
Lorena de Cássia Neres FerrazInstituto René Rachou, Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.
Ana Thereza ChavesFaculdade de Medicina, UFMG, Belo Horizonte, Minas Gerais, Brazil.
Kelly Alves BicalhoInstituto René Rachou, Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.
Carlos Eduardo Calzavara SilvaInstituto René Rachou, Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.
Alexander BirbrairDepartamento de Patologia, ICB, UFMG, Belo Horizonte, Minas Gerais, Brazil.
Marcelo Antônio Pascoal XavierInstituto René Rachou, Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.
Alfredo Miranda de GoesDepartamento de Bioquímica e Imunologia, ICB, UFMG, Belo Horizonte, Minas Gerais, Brazil.
Rodrigo Corrêa-OliveiraInstituto René Rachou, Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.
Érica Alessandra Rocha AlvesInstituto René Rachou, Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.
Adriana BozziInstituto René Rachou, Fiocruz Minas, Belo Horizonte, Minas Gerais, Brazil.ORCID 0000-0002-7126-0382
Universidade Federal de Minas Gerais · BRUniversidade Estadual de Santa Cruz · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn view of the potential immunosuppressive and regenerative properties of mesenchymal stem cells (MSC), we investigated whether transplantation of adipose tissue-derived stem cells (ASC) could be used to control the granulomatous reaction in the liver of mice infected with Schistosoma mansoni after Praziquantel (PZQ) treatment. METHODOLOGY/PRINICPAL

findingsC57BL/6 mice infected with S. mansoni were treated with PZQ and transplanted intravenously with ASC from uninfected mice. Liver morpho-physiological and immunological analyses were performed. The combined PZQ/ASC therapy significantly reduced the volume of hepatic granulomas, as well as liver damage as measured by ALT levels. We also observed that ASC accelerated the progression of the granulomatous inflammation to the advanced/curative phase. The faster healing interfered with the expression of CD28 and CTLA-4 molecules in CD4+ T lymphocytes, and the levels of IL-10 and IL-17 cytokines, mainly in the livers of PZQ/ASC-treated mice.

conclusionsOur results show that ASC therapy after PZQ treatment results in smaller granulomas with little tissue damage, suggesting the potential of ASC for the development of novel therapeutic approaches to minimize hepatic lesions as well as a granulomatous reaction following S. mansoni infection. Further studies using the chronic model of schistosomiasis are required to corroborate the therapeutic use of ASC for schistosomiasis.

Indexed as

Adipose TissueAnimalsCell- and Tissue-Based TherapyCytokinesDisease Models, AnimalGranulomaLiverLiver DiseasesMaleMiceMice, Inbred C57BLPraziquantelSchistosoma mansoniSchistosomiasisSchistosomiasis mansoniCytokinesPraziquantel

Identifiers

PMID32853206
PMCPMC7480869
OpenAlexW3080256512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.